The complete blood cell count in a refined cohort of preterm NEC: The importance of gestational age and day of diagnosis when using the CBC to estimate mortality

Journal of Perinatology

Volumn 36, Issue 2, 2016, Pages 121-125

  Gordon, P V ^a,b   Swanson, J R ^c   Clark, R ^b   Spitzer, A ^b  

^a Sacred Heart Children's Hospital   (United States)

^b Pediatrix Corporation   (United States)

^c UNIVERSITY OF VIRGINIA CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CELL COUNT; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMAN; HUMAN CELL; INFANT; INFANT MORTALITY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NECROTIZING ENTEROCOLITIS; PREDICTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVOR; THROMBOCYTE COUNT; BLOOD; EARLY DIAGNOSIS; ENTEROCOLITIS, NECROTIZING; EPIDEMIOLOGY; MORTALITY; NEWBORN; PREDICTIVE VALUE; PREMATURITY; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VERY LOW BIRTH WEIGHT; VIRGINIA;

BLOOD CELL COUNT; EARLY DIAGNOSIS; ENTEROCOLITIS, NECROTIZING; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; ROC CURVE; TIME FACTORS; VIRGINIA;

EID: 84956604137     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2015.162     Document Type: Article

References (31)

1. Kim JH. Necrotizing enterocolitis: the road to zero. Semin Fetal Neonatal Med 2014; 19(1): 39-44.
2. Christensen RD, Gordon PV, Besner GE. Can we cut the incidence of necrotizing enterocolitis in half - today? Fetal Pediatr Pathol 2010; 29(4): 185-198.
3. Benjamin J, Chong E, Reynolds J, Gordon PV. Detailed analysis of NEC risks across a decade in a low incidence NICU: can we drive the incidence of NEC toward zero? EJ Neonatol Res 2012; 2: 182-189.
4. Ellsbury DL, Ursprung R. A quality improvement approach to optimizing medication use in the neonatal intensive care unit. Clin Perinatol 2012; 39(1): 1-10.
5. Bloom BT, Craddock A, Delmore PM, Kurlinski JP, Voelker M, Landfish N et al. Reducing acquired infections in the NICU: observing and implementing meaningful differences in process between high and low acquired infection rate centers. J Perinatol 2003; 23(6): 489-492.
6. Gordon PV, Swanson JR, Attridge JT, Clark R. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria? J Perinatol 2007; 27 (11): 661-671.
7. Gordon P, Christensen R, Weitkamp JH, Maheshwari A. Mapping the new world of necrotizing enterocolitis (NEC): review and opinion. EJ Neonatol Res 2012; 2(4): 145-172.
8. Gordon PV, Swanson JR. Necrotizing enterocolitis is one disease with many origins and potential means of prevention. Pathophysiology 2014; 21(1): 13-19.
9. Gordon PV. Necrotizing enterocolitis (NEC) and darwinism (reviewing the evolutionary basis for NEC). EJ Neonatol Res 2013; 3(1): 23-30.
10. Chucri TM, Monteiro JM, Lima AR, Salvadori ML, Kfoury JR Jr, Miglino MA. A review of immune transfer by the placenta. J Reprod Immunol 2010; 87(1-2): 14-20.
11. Cianga P, Medesan C, Richardson JA, Ghetie V, Ward ES. Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur J Immunol 1999; 29: 2515-2523.
12. Brawand D, Wahli W, Kaessmann H. Loss of egg yolk genes in mammals and the origin of lactation and placentation. PLoS Biol 2008; 6(3): e63.
13. Swanson JR, Jilling T, Lu J, Landseadel JB, Marcinkiewicz M, Gordon PV. Ileal immunoglobulin binding by the neonatal Fc receptor: a previously unrecognized mechanism of protection in the neonatal rat model of necrotizing enterocolitis? EJ Neonatol Res 2011; 1(1): 12-22.
14. Gordon PV, Clark R, Swanson JR, Spitzer A. Can a national dataset generate a nomogram for necrotizing enterocolitis onset? J Perinatol 2014; 34(10): 732-735.
15. Banyasz I, Bokodi G, Vasarhelyi B, Treszl A, Derzbach L, Szabo A et al. Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. Eur Cytokine Netw 2006; 17: 266-270.
16. Moonen RM, Paulussen AD, Souren NY, Kessels AG, Rubio-Gozalbo ME, Villamor E. Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis. Pediatr Res 2007; 62: 188-190.
17. Sampath V, Le M, Lane L, Patel AL, Cohen JD, Simpson PM et al. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 2011; 169: e51-e57.
18. More K, Athalye-Jape G, Rao S, Patole S. Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low-birth-weight infants. Am J Perinatol 2013; 30(10): 849-856.
19. Woods CW, Oliver T, Lewis K, Yang Q. Development of necrotizing enterocolitis in premature infants receiving thickened feeds using SimplyThick. J Perinatol 2012; 32: 150-152.
20. Remon J, Kampanatkosol R, Kaul RR, Muraskas JK, Christensen RD, Maheshwari A. Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance. J Perinatol 2014; 34(7): 549-554.
21. Christensen RD, Lambert DK, Gordon PV, Baer VL, Gerday E, Henry E. Neonates presenting with bloody stools and eosinophilia can progress to two different types of necrotizing enterocolitis. J Perinatol 2012; 32(11): 874-879.
22. Christensen RD, Baer VL, Gordon PV, Henry E, Whitaker C, Andres RL, Bennett ST. Reference ranges for lymphocyte counts of neonates: associations between abnormal counts and outcomes. Pediatrics 2012; 129(5): e1165-e1172.
23. Sylvester KG, Ling XB, Liu GY, Kastenberg ZJ, Ji J, Hu Z et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr 2014; 164(3): 607-612.e1-7.
24. Sylvester KG, Ling XB, Liu GY, Kastenberg ZJ, Ji J, Hu Z et al. A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants. Gut 2014; 63(8): 1284-1292.
25. Evennett NJ, Hall NJ, Pierro A, Eaton S. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010; 45(4): 735-740.
26. Aydemir O, Aydemir C, Sarikabadayi YU, Emre Canpolat F, Erdeve O, Biyikli Z et al. Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med 2012; 25(11): 2237-2241.
27. Stone ML, Tatum PM, Weitkamp JH, Mukherjee AB, Attridge J, McGahren ED et al. Abnormal heart rate characteristics before clinical diagnosis of necrotizing enterocolitis. J Perinatol 2013; 33(11): 847-850.
28. Däbritz J, Jenke A, Wirth S, Foell D. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr 2012; 161(6): 1059-1064.
29. Murgas Torrazza R, Li N, Young C, Kobeissy F, Chow M, Chen S et al. Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology 2013; 104(3): 234-242.
30. Tayman C, Tonbul A, Kahveci H, Uysal S, Koseoğlu B, Tatli MM et al. C5a, a complement activation product, is a useful marker in predicting the severity of necrotizing enterocolitis. Tohoku J Exp Med 2011; 224(2): 143-150.
31. Garner CE, Ewer AK, Elasouad K, Power F, Greenwood R, Ratcliffe NM et al. Analysis of faecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study. J Pediatr Gastroenterol Nutr 2009; 49(5): 559-565.